Interleukin-I antagonists.
Dower
S K
SK
Immunex Research and Development Corporation, Seattle, WA 98101, USA.
Fanslow
W
W
Jacobs
C
C
Waugh
S
S
Sims
J E
JE
Widmer
M B
MB
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000628:therapy; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000502:physiology*; D011485:Protein Binding; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000502:physiology*; D011994:Recombinant Proteins; D012795:Sialoglycoproteins; D012882:Skin Tests; D012995:Solubility
C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D012795:Sialoglycoproteins